[
    [
        {
            "time": "2019-07-26",
            "original_text": "Edited Transcript of ABBV earnings conference call or presentation 26-Jul-19 1:00pm GMT",
            "features": {
                "keywords": [
                    "ABBV",
                    "earnings",
                    "conference",
                    "call",
                    "presentation"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Edited Transcript of ABBV earnings conference call or presentation 26-Jul-19 1:00pm GMT",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-07-26",
            "original_text": "Noteworthy Monday Option Activity: SYNA, ABBV, VGR",
            "features": {
                "keywords": [
                    "SYNA",
                    "ABBV",
                    "VGR",
                    "option",
                    "activity"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "pharmaceuticals",
                    "utilities"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Noteworthy Monday Option Activity: SYNA, ABBV, VGR",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-07-26",
            "original_text": "Pfizer to Combine Off-Patent Drug Business With Mylan",
            "features": {
                "keywords": [
                    "Pfizer",
                    "off-patent",
                    "drug",
                    "business",
                    "Mylan",
                    "combine"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Pfizer to Combine Off-Patent Drug Business With Mylan",
                "Correlation": 3,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]